Early detection of pancreatic cancer by liquid biopsy "PANLIPSY": a french nation-wide study project.
Thomas Bardol, Antoine M Dujon, Valerie Taly...
https://pubmed.ncbi.nlm.nih.gov/38853244Actively Recruiting
Age: 18Years - 120Years
All Genders
ID06128343
Anatomical-Clinical Base of Adenocarcinoma Pancreatic
Led by University Hospital, Toulouse · Updated on 2026-03-19
1500
Participants Needed
8
Research Sites
4 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Pancreatic cancer is a leading cause of cancer death in Western countries, with over 90% of cases caused by adenocarcinoma. Surgical removal of the tumor is currently the only curative treatment but is possible in only 10 to 15% of cases. This research aims to enhance understanding and treatment of pancreatic adenocarcinoma by enriching an existing biobank with fresh tumor tissue and genetic analysis to support future studies on diagnostic tools, tumor development, therapeutic targets, and chemotherapy response.
CONDITIONS
Brief Title
Anatomical-Clinical Base of Adenocarcinoma Pancreatic
Who Can Participate
Age: 18Years - 120Years
All Genders
Eligibility Criteria
You may qualify if you...
- Patient with pancreatic mass syndrome explored by ultrasound endoscopy with cytopuncture
- Patient with pancreatic mass syndrome explored by an abdominal scanner with and without injection of product contrast and/or puncture of the mass or secondary lesions by radiological route
- Patient with pancreatic adenocarcinoma proven histologically and/or cytologically
- Age between 18 and 120 years
You will not qualify if you...
- Patient with a pancreatic tumor whose histological analysis is not an adenocarcinoma
- Pregnant or breastfeeding patient
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
1
2
3
Your Study Journey
Screening
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 to 2 visits depending on diagnostic procedures
Diagnostic Evaluation
Duration - Up to 5 years
Participants undergo collection of biological samples including whole blood and micro-biopsy from pancreatic tissue to support research.
Visits occur as needed for sample collection during routine clinical care
Long-term Monitoring
Duration - Up to 5 years
Participants are observed over time to enrich the prospective BACAP collection and support future research.
Periodic visits may occur depending on clinical follow-up
Trial Site Locations
Total: 8 locations
1
Béthune hospital center
Béthune, France, 62408
Not Yet Recruiting
2
Haut-Lévêque Hospital
Bordeaux, France, 33604
Not Yet Recruiting
3
Huriez Hospital
Lille, France, 59037
Not Yet Recruiting
4
Jean Mermoz private hosptila
Lyon, France, 69008
Not Yet Recruiting
5
Saint Eloi Hospital
Montpellier, France, 34295
Not Yet Recruiting
6
Regional Cancer Center From Montpellier
Montpellier, France, 34298
Not Yet Recruiting
7
PAU hospital
Pau, France, 6400
Not Yet Recruiting
8
Rangueil hospital
Toulouse, France, 31059
Actively Recruiting
Loading map...
Research Team
B
Barbara BOURNET, MD, PhD
C
Cindy CANIVET, PhD
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here